CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-11 | Sabag Mark See "Remarks" below | Grant or award · Restricted Share Units | +19,040 | 19,040 | ||
| 2020-02-11 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award · Restricted Share Units | +17,850 | 17,850 | ||
| 2020-02-11 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +13,090 | 13,090 | ||
| 2020-02-10 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −12,538 | $12.24 | $153K | 2,974.39 |
| 2020-02-10 | O'Grady Brendan P. EVP, North America Commercial | Sale | −4,799 | $12.27 | $59K | 13,456.49 |
| 2020-02-10 | Nazzi Gianfranco EVP, Growth Markets Commercial | Sale | −4,155 | $12.24 | $51K | 18,464.36 |
| 2020-02-10 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −5,544 | $12.27 | $68K | 33,329.51 |
| 2020-02-10 | Drape Eric Executive VP Global Operations | Sale | −3,144 | $12.24 | $38K | 20,618 |
| 2020-02-10 | Dethlefs Sven EVP Global Marketing&Portfolio | Sale | −5,669 | $12.27 | $70K | 18,060.7 |
| 2020-02-10 | Daniell Richard Exec. VP, European Commercial | Sale | −6,199 | $12.24 | $76K | 8,612 |
| 2020-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +12,538 | 15,512.39 | ||
| 2020-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −12,538 | 25,076 | ||
| 2020-02-09 | Schultz Kare President and CEO | Option exercise | +26,867 | 90,480 | ||
| 2020-02-09 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −26,867 | 53,734 | ||
| 2020-02-09 | Sabag Mark See "Remarks" below | Option exercise | +15,523 | 72,130.54 | ||
| 2020-02-09 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −15,523 | 31,046 | ||
| 2020-02-09 | O'Grady Brendan P. EVP, North America Commercial | Option exercise | +16,120 | 18,255.49 | ||
| 2020-02-09 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −16,120 | 32,241 | ||
| 2020-02-09 | Nazzi Gianfranco EVP, Growth Markets Commercial | Option exercise | +11,941 | 22,619.36 | ||
| 2020-02-09 | Nazzi Gianfranco EVP, Growth Markets Commercial | Option exercise · Restricted Share Units | −11,941 | 23,882 |
Page 60 of 76 · 1,517 trades